The Obama administration released its Fiscal Year 2011 budget proposal this week, including the federal drug control budget. On the drug budget, the Obama administration is generally following the same course as the Bush administration and appears to be flying on autopilot.
According to the Office of National Drug Control Policy (ONDCP -- the drug czar's office), the administration is requesting $15.5 billion for drug control, an increase of 3.5% over the current budget. Drug law enforcement funding would grow from $9.7 billion this year to $9.9 billion in 2011, an increase of 5.2%. Demand side measures, such as prevention and treatment, also increased from $5.2 billion this year to $5.6 billion next year.
The Obama drug budget largely maintains the roughly two-to-one imbalance between spending on treatment and prevention and spending on law enforcement. Drug Czar Gil Kerlikowske called the imbalanced budget "balanced."
Highlights and lowlights:
- Funding for the Substance Abuse and Mental Health Services Administration prevention programs (SAMHSA) is set at $254.2 million, up $29.6 million from this year, while funding for SAMHSA treatment programs is set at $635.4 million, up $101.2 million from this year.
- Funding for ONDCP's Drug Free Communities program is set at $85.5 million, down $9.5 million from this year.
- Funding for the widely challenged National Youth Anti-Drug Media Campaign is set at $66.5 million, an increase of more than 50% over this year.
- The Arrestee Drug Abuse Monitoring II program (ADAM) is funded at $10 million. It got no money this year.
- Funding for the Department of Health and Human Services Substance Abuse Prevention and Treatment program is set at $1.799 billion, the same as this year.
- Funding for the Second Chance Act for reintegrating people completing prison sentences is set at $50 million, a whopping 66% increase over this year.
- Funding for the Justice Department's Organized Crime Drug Enforcement Task Force is set at $579.3 million, up $50.8 million over this year.
- Funding for the High Intensity Drug Trafficking Areas (HIDTA) program is set at $210 million, down $29 million from this year.
- Funding for the Defense Department's counternarcotics efforts in Afghanistan is set at $501.5 billion, up about one-third over this year.
- Funding for State Department counternarcotics activities in West Africa is set at $13.2 million, up $10 million from this year.
- Funding for State Department counternarcotics activities in Colombia is set at $178.6 million, down $26.6 million from this year.
- Funding for the DEA is set at $2.131 billion, up 5.5% over this year. That pays for 8,399 employees, 4,146 of whom are DEA agents.
- Funding for the Office of Justice Programs' Byrne grant program, Southwest Border Prosecutor Initiative, Northern Border Prosecutor Initiative, and Prescription Drug Monitoring program has been eliminated.
"The new budget proposal demonstrates the Obama administrations' commitment to a balanced and comprehensive drug strategy," said Kerlikowske. "In a time of tight budgets and fiscal restraint, these new investments are targeted at reducing Americans' drug use and the substantial costs associated with the health and social consequences of drug abuse."
Drug reformers tended to disagree with Kerlikowske's take on the budget. "This is certainly not change we can believe in," said Bill Piper, national affairs director for the Drug Policy Alliance. "It's extremely similar to the Bush administration drug budgets, especially in terms of supply side versus demand side. In that respect, it's extremely disappointing. There's nothing innovative there."
"This budget reflects the same Bush-era priorities that led to the total failure of American drug policy during the last decade," said Aaron Houston, director of government relations for the Marijuana Policy Project. "One of the worst examples is $66 million requested for the National Youth Anti-Drug Media Campaign when every independent study has called it a failure. The president is throwing good money after bad when what we really need is a new direction."
Houston also took umbrage with the accounting legerdemain that continues to allow ONDCP to understate the real cost of federal drug policies. "It's disconcerting to see the Obama administration employ the same tactics in counting the drug budget that the Bush administration did," said Houston. "Congress told ONDCP in 2006 to stop excluding certain items from the budget, and we had a Democratic committee chairman excoriate John Walters over his cooking of the books, but it doesn't appear they've done anything to stop that. Maybe they have to cook the books to make this look like a successful program."
But reformers also noted that some good drug policy news had already come out of the Obama administration. They also suggested that the real test of Obama's direction in drug policy would come in March, when Kerlikowske releases the annual national drug control strategy.
"I'm a little disappointed," said Keith Stroup, founder of the National Organization for the Reform of Marijuana Laws, "but I think there is a significant difference in the environment from the Bush years. Maybe not in this budget, but things like issuing those Department of Justice regulations on medical marijuana have made a major difference."
"They are unwilling or unable to change the drug war budget, but the true measure of their commitment to a shift in drug policy will be the national drug control strategy that comes out in a few weeks," said Piper. "The question is will their drug strategy look like Bush's and like their drug budget does, or will they articulate a new approach to drug policy more in line with the president's comments on the campaign trail that drug use should be treated as a public health issue, not a criminal justice one."
The Obama administration's decision to not interfere with medical marijuana in the states was one example of a paradigm shift, said Piper. So was its support for repealing the federal needle exchange funding ban and ending the sentencing disparity between crack and powder cocaine offenses.
"In a lot of ways, the budget trimming that comes out of the White House is a fraud because they know Congress won't make those cuts," said Piper. "I wonder if that's the game Obama is playing with the Byrne grants. That's the kind of thing they can articulate in the drug strategy if they wanted to. They should at least talk about the need to shift from the supply side to the demand side approach. They could even admit that this year's budget does not reflect that, but still call for it."
This is only the administration's budget request, of course. What it will look like by the time Congress gets through with it is anybody's guess. But it strongly suggests that, so far, there's not that much new under the sun in the Obama White House when it comes to the drug budget.